Electromed (ELMD) Announces $5M Share Buyback

Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that on March 6, 2025, its board of directors authorized the repurchase of up to $5.0 million of Electromed common stock.

The timing and amount of share repurchases pursuant to the authorization, if any, will be determined by management based on market conditions and other considerations. Repurchases may be made from time to time on the open market at prevailing market prices, in privately negotiated transactions, in block trades and/or through other legally permissible means, depending on market conditions and in accordance with applicable rules and regulations. Electromed’s board of directors expects to review the share repurchase authorization periodically and may approve changes to its terms and size.

“I am excited to announce Electromed’s next share repurchase authorization, which reflects our confidence in the strength of our business. Our management team and Board are committed to creating additional shareholder value. We believe deploying our excess cash reserves to opportunistically buy back stock helps us to return capital to our shareholders while maintaining both a strong balance sheet and the financial flexibility to invest in future growth opportunities,” said Jim Cunniff, President, and Chief Executive Officer.

You May Also Be Interested In

• GLJ Research Downgrades Fluence Energy Inc. (FLNC) to Hold
• Huhutech unit wins multi-year tool hook-up contract in Hiroshima
• Nextpower receives U.S. patent for solar trunk bus technology